Correlation Between Silence Therapeutics and Contineum Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Silence Therapeutics and Contineum Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silence Therapeutics and Contineum Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silence Therapeutics PLC and Contineum Therapeutics, Class, you can compare the effects of market volatilities on Silence Therapeutics and Contineum Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silence Therapeutics with a short position of Contineum Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silence Therapeutics and Contineum Therapeutics,.
Diversification Opportunities for Silence Therapeutics and Contineum Therapeutics,
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Silence and Contineum is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Silence Therapeutics PLC and Contineum Therapeutics, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Contineum Therapeutics, and Silence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silence Therapeutics PLC are associated (or correlated) with Contineum Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Contineum Therapeutics, has no effect on the direction of Silence Therapeutics i.e., Silence Therapeutics and Contineum Therapeutics, go up and down completely randomly.
Pair Corralation between Silence Therapeutics and Contineum Therapeutics,
Considering the 90-day investment horizon Silence Therapeutics PLC is expected to generate 1.06 times more return on investment than Contineum Therapeutics,. However, Silence Therapeutics is 1.06 times more volatile than Contineum Therapeutics, Class. It trades about 0.15 of its potential returns per unit of risk. Contineum Therapeutics, Class is currently generating about 0.02 per unit of risk. If you would invest 477.00 in Silence Therapeutics PLC on September 1, 2025 and sell it today you would earn a total of 197.00 from holding Silence Therapeutics PLC or generate 41.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Silence Therapeutics PLC vs. Contineum Therapeutics, Class
Performance |
| Timeline |
| Silence Therapeutics PLC |
| Contineum Therapeutics, |
Silence Therapeutics and Contineum Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Silence Therapeutics and Contineum Therapeutics,
The main advantage of trading using opposite Silence Therapeutics and Contineum Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silence Therapeutics position performs unexpectedly, Contineum Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Contineum Therapeutics, will offset losses from the drop in Contineum Therapeutics,'s long position.| Silence Therapeutics vs. Lamar Advertising | Silence Therapeutics vs. Purple Beverage | Silence Therapeutics vs. Fevertree Drinks Plc | Silence Therapeutics vs. ScanSource |
| Contineum Therapeutics, vs. GameSquare Holdings | Contineum Therapeutics, vs. ToysRUs ANZ Limited | Contineum Therapeutics, vs. Xenia Hotels Resorts | Contineum Therapeutics, vs. American Hotel Income |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |